Retour
67
Fourchette du Jour
92,19 €
92,19 €
Fourchette 52 Semaines
80,91 €
110,40 €
Volume
3 750
Moyenne 50J / 200J
87,88 €
/
92,53 €
Clôture Précédente
92,19 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 21,3 | 0,4 |
| P/B | 6,3 | 2,9 |
| ROE % | 32,6 | 3,7 |
| Net Margin % | 33,9 | 3,8 |
| Rev Growth 5Y % | -0,9 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue declined -0,94% annually over 5 years
Earnings grew 186,92% over the past year
ROE of 32,58% indicates high profitability
Net margin of 33,87% shows strong profitability
Debt/Equity of 0,20 — conservative balance sheet
Generating 43,73M in free cash flow
Croissance
Revenue Growth (5Y)
-0,94%
Revenue (1Y)26,57%
Earnings (1Y)186,92%
FCF Growth (3Y)N/A
Qualité
Return on Equity
32,58%
ROIC9,99%
Net Margin33,87%
Op. Margin18,19%
Sécurité
Debt / Equity
0,20
Current Ratio3,02
Interest Coverage37,85
Valorisation
P/E Ratio
21,31
P/B Ratio6,34
EV/EBITDA40,48
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26,57% | Revenue Growth (3Y) | 18,29% |
| Earnings Growth (1Y) | 186,92% | Earnings Growth (3Y) | 711,95% |
| Revenue Growth (5Y) | -0,94% | Earnings Growth (5Y) | -5,21% |
| Profitability | |||
| Revenue (TTM) | 221,31M | Net Income (TTM) | 74,96M |
| ROE | 32,58% | ROA | 18,98% |
| Gross Margin | 94,46% | Operating Margin | 18,19% |
| Net Margin | 33,87% | Free Cash Flow (TTM) | 43,73M |
| ROIC | 9,99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,20 | Current Ratio | 3,02 |
| Interest Coverage | 37,85 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 21,31 | P/B Ratio | 6,34 |
| P/S Ratio | 7,22 | PEG Ratio | 0,09 |
| EV/EBITDA | 40,48 | Dividend Yield | 0,01% |
| Market Cap | 1,60B | Enterprise Value | 1,63B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 221,31M | 174,86M | 158,15M | 196,34M | 229,83M |
| Net Income | 74,96M | 26,13M | 1,14M | 49,36M | 92,86M |
| EPS (Diluted) | 4,36 | 1,49 | 0,06 | 2,73 | 5,13 |
| Gross Profit | 209,05M | 166,67M | 148,54M | 182,70M | 213,39M |
| Operating Income | 40,26M | 6,47M | -3,83M | 44,07M | 92,45M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 394,93M | 349,64M | 340,52M | 393,26M | 368,39M |
| Total Liabilities | 142,48M | 141,29M | 147,08M | 170,30M | 190,47M |
| Shareholders' Equity | 251,74M | 208,36M | 193,44M | 222,96M | 177,92M |
| Total Debt | 50,53M | 51,08M | 43,67M | 42,63M | 49,33M |
| Cash & Equivalents | 17,81M | 63,24M | 60,02M | 149,81M | 113,35M |
| Current Assets | 283,31M | 250,25M | 252,60M | 275,18M | 295,23M |
| Current Liabilities | 93,84M | 82,69M | 95,89M | 97,32M | 86,35M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#58 of 326
Activité Récente
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026